CNY 63.18
(-0.44%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 1.35 Billion | 1.21 Billion | 1.06 Billion | 711.81 Million | 571.61 Million | 552.47 Million |
Cost of Revenue | 1.01 Billion | 950.12 Million | 826.61 Million | 559.88 Million | 443.48 Million | 435.56 Million |
Gross Profit | 342.71 Million | 261.7 Million | 236.38 Million | 151.92 Million | 128.13 Million | 116.91 Million |
Operating Expenses | 124.64 Million | 93.6 Million | 88.31 Million | 62.06 Million | 47.13 Million | 44.51 Million |
Selling, General and Administrative Expenses | 79.81 Million | 27.47 Million | 14.82 Million | -11.48 Million | -22.4 Million | -6.73 Million |
Research and Development Expenses | 50.95 Million | 43.48 Million | 37.8 Million | 23.76 Million | 20.65 Million | 19.38 Million |
Other Expenses | -6.12 Million | -1.42 Million | 23.31 Million | 73.23 Million | 87.57 Million | 62.53 Million |
Cost and Expenses | 1.13 Billion | 1.04 Billion | 914.93 Million | 621.94 Million | 490.61 Million | 480.07 Million |
Operating Income | 218.06 Million | 162.79 Million | 136.51 Million | 78.69 Million | 71.07 Million | 63.99 Million |
Interest Expense | 3.64 Million | 7.39 Million | 14.74 Million | 40.96 Million | 41.89 Million | 36.26 Million |
Income Tax Expense | 30.06 Million | 20.22 Million | 17.68 Million | 10.28 Million | 9.34 Million | 8.12 Million |
Earnings before Tax | 230.78 Million | 161.37 Million | 138.3 Million | 78.5 Million | 71.11 Million | 63.95 Million |
Net Income | 200.71 Million | 141.15 Million | 120.61 Million | 68.21 Million | 61.77 Million | 55.82 Million |
Earnings Per Share Basic | 2.69 | 1.89 | 1.62 | 0.91 | 0.83 | 1.10 |
Earnings Per Share Diluted | 2.68 | 1.89 | 1.62 | 0.91 | 0.83 | 1.10 |
Weighted Average Shares Outstanding | 74.61 Million | 74.66 Million | 74.66 Million | 74.66 Million | 74.66 Million | 50.74 Million |
Weighted Average Shares Outstanding (Diluted) | 74.89 Million | 74.66 Million | 74.66 Million | 74.66 Million | 74.66 Million | 50.74 Million |
Gross Margin | 0.25 | 0.22 | 0.22 | 0.21 | 0.22 | 0.21 |
EBIT Margin | 0.19 | 0.16 | 0.17 | 0.20 | 0.22 | 0.19 |
Profit Margin | 0.15 | 0.12 | 0.11 | 0.10 | 0.11 | 0.10 |
EBITDA | 258.78 Million | 185.6 Million | 168.63 Million | 104.7 Million | 84.11 Million | 76.75 Million |
Earnings Before Tax Margin | 0.16 | 0.13 | 0.13 | 0.11 | 0.12 | 0.12 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 366.95 Million | 354.96 Million | 348.32 Million | 1.35 Billion | 406.27 Million | 372.35 Million |
Cost of Revenue | 274.61 Million | 268.75 Million | 262.59 Million | 1.01 Billion | 301.9 Million | 279.8 Million |
Gross Profit | 92.33 Million | 86.2 Million | 85.72 Million | 343.2 Million | 104.36 Million | 92.55 Million |
Operating Expenses | 40.4 Million | 40.13 Million | 32.38 Million | 125.11 Million | 35.34 Million | 30.24 Million |
Selling, General and Administrative Expenses | 47.31 Million | 24.41 Million | 16.89 Million | - | -7 Million | 34.45 Million |
Research and Development Expenses | 14.69 Million | 15.55 Million | 15.34 Million | - | 17.9 Million | 10.74 Million |
Other Expenses | -21.6 Million | -170.09 Thousand | -140.91 Thousand | 12.71 Million | 5.71 Million | 4.98 Million |
Cost and Expenses | 315.02 Million | 308.89 Million | 294.98 Million | 1.13 Billion | 337.25 Million | 310.04 Million |
Operating Income | 51.44 Million | 46.07 Million | 53.34 Million | 218.06 Million | 66.95 Million | 60.81 Million |
Interest Expense | 596.17 Thousand | 686.48 Thousand | 846.67 Thousand | 3.54 Million | 712.8 Thousand | 839.03 Thousand |
Income Tax Expense | 6.31 Million | 5.11 Million | 9.16 Million | 30.06 Million | 9.33 Million | 8.94 Million |
Earnings before Tax | 51.4 Million | 48.17 Million | 59.83 Million | 230.78 Million | 72.66 Million | 65.8 Million |
Net Income | 45.08 Million | 43.06 Million | 50.66 Million | 200.71 Million | 63.33 Million | 56.85 Million |
Earnings Per Share Basic | 0.58 | 0.56 | 0.70 | - | 0.85 | 0.76 |
Earnings Per Share Diluted | 0.58 | 0.55 | 0.64 | - | 0.85 | 0.75 |
Weighted Average Shares Outstanding | 77.22 Million | 77.22 Million | 72.71 Million | 74.66 Million | 74.66 Million | 74.66 Million |
Weighted Average Shares Outstanding (Diluted) | 77.73 Million | 78.29 Million | 79.16 Million | 74.89 Million | 74.66 Million | 75.65 Million |
Gross Margin | 0.25 | 0.24 | 0.25 | 0.25 | 0.26 | 0.25 |
EBIT Margin | 0.14 | 0.15 | 0.17 | - | 0.19 | 0.19 |
Profit Margin | 0.12 | 0.12 | 0.15 | 0.15 | 0.16 | 0.15 |
EBITDA | 52 Million | 52.11 Million | 58.03 Million | - | 76.26 Million | 69.01 Million |
Earnings Before Tax Margin | 0.14 | 0.13 | 0.15 | 0.16 | 0.16 | 0.16 |
SLVMF
DRMA
TROX
STYRENIX
EICHERMOT
120110